Assessing Capgemini (ENXTPA:CAP) Valuation After Recent Share Price Weakness

How Capgemini’s recent share performance frames the investment question

Capgemini (ENXTPA:CAP) has drawn attention after a series of weak returns, with the share price down over the past week, month, past 3 months, year to date, and the past year, prompting closer scrutiny from investors.

The company reports annual revenue of about €22.1b and net income of roughly €1.6b, with both metrics showing annual growth. This provides a concrete financial base for investors to weigh against the recent share price performance.

See our latest analysis for Capgemini.

With the share price at €127.85, Capgemini’s recent 1 month share price return of 10.66% and 1 year total shareholder return of 25.41% indicate fading momentum after earlier gains over the past five years.

If Capgemini’s pullback has you reassessing opportunities in tech, it could be a good moment to widen your search and check out high growth tech and AI stocks.

So, with Capgemini reporting €22.1b in revenue and €1.6b in net income while the share price remains below some valuation estimates, should investors view this as a potential mispricing, or assume that the market is already accounting for future growth in its current valuation?

Most Popular Narrative: 25.6% Undervalued

Capgemini’s most followed narrative puts fair value at €171.93 versus the last close of €127.85, setting up a clear valuation gap for investors to assess.

Capgemini's expanding leadership and strong deal wins in advanced cloud, data, and artificial intelligence (including Gen AI and Agentic AI) are positioning the company to benefit from the accelerating client demand for digital transformation, supporting a pipeline for higher value, higher margin contracts that should drive long term revenue and margin expansion.

Read the complete narrative.

Curious what earnings path and margin profile need to hold for that valuation anchor, especially with a higher future earnings multiple and specific growth assumptions baked in?

Result: Fair Value of €171.93 (UNDERVALUED)

Have a read of the narrative in full and understand what's behind the forecasts.

However, you still need to weigh the risk that weaker demand in key European markets or sustained margin pressure from pricing competition could undermine this positive earnings trajectory.

Find out about the key risks to this Capgemini narrative.

Another view: earnings multiple sends a different signal

Our DCF work points to value of €212.36 per share, so at €127.85 Capgemini screens as undervalued on future cash flows. Yet on a P/E of 13.8x, the stock trades above peers at 11.4x, even though it sits below a fair ratio of 25.1x. Which signal do you put more weight on?

See what the numbers say about this price — find out in our valuation breakdown.

Build Your Own Capgemini Narrative

If you look at the numbers and reach a different conclusion, or simply prefer to test your own assumptions, you can build a complete view in just a few minutes with Do it your way.

A great starting point for your Capgemini research is our analysis highlighting 3 key rewards and 1 important warning sign that could impact your investment decision.

Ready for more investment ideas beyond Capgemini?

If you stop with just one company, you risk missing ideas that might fit your goals better. Use the screener to keep your opportunity set wide.

• Scan for companies the market may be overlooking by checking out these 868 undervalued stocks based on cash flows that could offer more appealing prices relative to their fundamentals.
• Explore developments in artificial intelligence by focusing on these 23 AI penny stocks that are tied to real business models rather than just headlines.
• Target income focused opportunities by zeroing in on these 14 dividend stocks with yields > 3% that might support a steadier stream of cash returns.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com